Literature DB >> 22526907

Laparoscopic hyperthermic intraperitoneal chemotherapy: indications, aims, and results: a systematic review of the literature.

Enrico Facchiano1, Domenico Risio, Reza Kianmanesh, Simon Msika.   

Abstract

PURPOSE: To evaluate laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) with neoadjuvant, adjuvant, or palliative purpose in order to discuss potential clinical implications.
METHODS: A systematic search of PubMed's Medline through August 2011 using the keywords laparoscopic, hyperthermic, and chemotherapy.
RESULTS: Eight studies encompassing a total of 183 patients were considered. The indications for laparoscopic HIPEC was neoadjuvant in 5 patients, adjuvant in 102 patients, and palliative in 76 patients. There were 13 minor complications not requiring repeat operation, and no deaths related to procedure were recorded. When performed to treat refractory malignant ascites, the procedure was effective in 95 % of cases.
CONCLUSIONS: Laparoscopic HIPEC appears to be a safe and effective procedure when performed to treat malignant ascites refractory to less aggressive treatments. The effectiveness of laparoscopy to perform HIPEC with neoadjuvant or adjuvant purpose needs to be confirmed by further studies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22526907     DOI: 10.1245/s10434-012-2360-0

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  13 in total

Review 1.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer.

Authors:  Ramakrishnan Ayloor Seshadri; Olivier Glehen
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

2.  Robotic-assisted cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC).

Authors:  Emmanuel Gabriel; Enrique Elli; Sanjay Bagaria; Nabil Wasif; Travis Grotz; John Stauffer; Pashtoon M Kasi; Horacio Asbun
Journal:  J Robot Surg       Date:  2018-05-05

3.  Peritoneal carcinomatosis of gastrointestinal tumors: where are we now?

Authors:  Cem Terzi; Naciye Cigdem Arslan; Aras Emre Canda
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

Review 4.  Review of management and treatment of peritoneal metastases from gastric cancer origin.

Authors:  Israel Manzanedo; Fernando Pereira; Ángel Serrano; Estíbalitz Pérez-Viejo
Journal:  J Gastrointest Oncol       Date:  2021-04

Review 5.  Gastric Cancer With Peritoneal Metastasis-A Comprehensive Review of Current Intraperitoneal Treatment Modalities.

Authors:  Aruna Prabhu; Deepti Mishra; Andreas Brandl; Yutaka Yonemura
Journal:  Front Oncol       Date:  2022-05-26       Impact factor: 5.738

6.  The Role of Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer.

Authors:  Ramakrishnan Ayloor Seshadri; Olivier Glehen
Journal:  Indian J Surg Oncol       Date:  2016-02-02

Review 7.  The Role of Hyperthermic Intraperitoneal Chemotherapy for Non-colorectal Peritoneal Surface Malignancies.

Authors:  Mackenzie C Morris; Jordan M Cloyd; John Hays; Sameer H Patel
Journal:  J Gastrointest Surg       Date:  2020-08-17       Impact factor: 3.452

Review 8.  Management of peritoneal surface malignancies in laparoscopic era: a concise review.

Authors:  Abhijit Shaligram
Journal:  Int J Surg Oncol (N Y)       Date:  2016-11-11

Review 9.  Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: patient selection and special considerations.

Authors:  Laura M Enomoto; Perry Shen; Edward A Levine; Konstantinos I Votanopoulos
Journal:  Cancer Manag Res       Date:  2019-05-07       Impact factor: 3.989

Review 10.  Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer.

Authors:  Adriana C Gamboa; Joshua H Winer
Journal:  Cancers (Basel)       Date:  2019-10-26       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.